Fatty acid profiles in mental disease. Part 1. Linolenate variations in schizophrenia.
Lipids were isolated from 6 patients suffering from schizophrenia and also from 6 age-matched healthy controls. The extracted lipids were fractionated into erythrocyte and plasma lipids. Column and thin-layer chromatography on silica gel were employed further to isolate the extracts into sub-classes within the major neutral and polar lipid classifications. The fatty acid composition of each sub-class was then monitored by gas chromatography after transmethylation. A significantly higher proportion of linolenic acid (18:3w3) was found in schizophrenics when compared with the controls. The change was reflected in both the neutral lipids and phospholipids from plasma and erythrocytes of the patients. On average, 8.7 +/- 2.6 and 3.9 +/- 1.5 mole % linolenate/100 mg lipid extract were obtained from the plasma of patients and healthy controls, respectively, while 8.6 +/- 2.3 and 3.0 +/- 1.2 mole/% linolenate/100 mg lipid were recorded from the red blood cells. The other fatty acids investigated did not show such significant differences between patient and healthy subject. A net increase in the amount of total fatty acid was recorded in the patients and it is thought that either linolenate alone or linolenate together with other polyunsaturated fatty acids not considered here are responsible for these observations. Correlations of these findings with the pathology of schizophrenia are discussed.
D000328:Adult; D002849:Chromatography, Gas; D005227:Fatty Acids / Q000097:blood / Q000378:metabolism; D006801:Humans; D008042:Linolenic Acids / Q000097:blood* / Q000378:metabolism; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008875:Middle Aged; D012559:Schizophrenia / Q000097:blood* / Q000378:metabolism
D005227:Fatty Acids; D008042:Linolenic Acids; D008055:Lipids